Therapy News and Research

RSS

Salk researchers discover molecule that destroys key HIV protein

One of the many challenges in treating HIV is that the virus can lie dormant in cells, quietly evading immune detection until it suddenly roars to life without warning and begins replicating furiously.

1 Jun 2018

Cancer cells can use lipid molecules as fuel for growth, shows study

Cancer cells can when the blood supply is low use lipid molecules as fuel instead of blood glucose. This has been shown in animal tumor models by researchers at Karolinska Institutet in Sweden in a study published in Cell Metabolism.

1 Jun 2018

Study finds reciprocal link between emotional distress and treatment side effects of prostate cancer

A new study published in the Journal of Urology® reports that men with prostate cancer who had worse urinary, bowel, and sexual function after surgery or radiotherapy than others experienced more emotional distress. Interestingly, the reverse was also true as experiencing more distress led to worse function.

1 Jun 2018

RaySearch signs research collaboration agreement with NIRS/QST for advancement of ion beam therapy

RaySearch has signed a research collaboration and licensing agreement with the National Institutes for Quantum and Radiological Science and Technology, a pioneer of ion beam technology based in Chiba, Japan. QST was established in 2016 when the National Institute of Radiological Sciences was merged with certain functions of the Japan Atomic Energy Agency.

31 May 2018

Prostate cancer survivors at higher risk of developing chronic diseases, study shows

Prostate cancer survivors taking androgen deprivation therapy (ADT), a treatment commonly used to block the release of male hormones, are at a higher risk of developing chronic diseases, according to new research published this week.

31 May 2018

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

Mesoblast Limited today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic ‘off-the-shelf’ CAR-T cells armed with multiple targeting receptors for use in solid cancers. Off the shelf CAR-T therapies have the potential to reduce costs dramatically and open up this very effective treatment to millions of cancer patients across the world.

31 May 2018

Scientists introduce combination approach to fight cancer

For efficient cancer therapy with few side effects, the active drug should selectively attain high concentration in the tumor. In the journal Angewandte Chemie, scientists have introduced a new approach, in which two synergistic drug components are combined into a dimer.

31 May 2018

UTSA scientists explore stuttering and develop new technology to optimize brain function

A team of researchers at The University of Texas at San Antonio received a two-year, $387,000 grant, from the National Institutes of Health (NIH), to develop technology that will identify brain activity patterns that contribute to stuttering and use that technology to train people how to optimize brain functions.

31 May 2018

New guideline for HER2 testing in breast cancer benefits patients and clinicians

Published today, a Focused Update to the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 (HER2) testing in breast cancer brings new levels of clarity that will benefit patients and clinical teams alike.

31 May 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

Impaired maternal-fetal environment associated with lower survival after surgery in newborns with CHD

Children who undergo surgery for congenital heart disease have lower survival rates by three years of age if there are specific problems during fetal development, such as hypertension in the mother or the newborn being born preterm or small for gestational age.

30 May 2018

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.

30 May 2018

Male thyroid cancer survivors face nearly 50% higher CVD risk than women, study suggests

Male thyroid cancer survivors have a nearly 50 percent higher risk of developing heart disease than women within five years of cancer diagnosis, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

30 May 2018

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

A radiotherapy drug that treats the rare neuroendocrine cancers pheochromocytoma and paraganglioma can be both effective and safe for patients, according to the findings of a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania.

30 May 2018

Scientists develop a new approach for efficient cancer therapy

For efficient cancer therapy with few side effects, the active drug should selectively attain high concentration in the tumor.

30 May 2018

Early-life seizures prematurely switch on key brain synapses related to autism

Early-life seizures prematurely switch on key synapses in the brain that may contribute to further neurodevelopmental delay in children with autism and other intellectual disabilities, suggests a new study from researchers at Penn Medicine published online in Cell Reports.

29 May 2018

Single spinal injection reverses chemotherapy-induced pain for months in mice

Researchers at University of California San Diego School of Medicine have found a new way to block a root cause of pain. The key is a naturally occurring protein called apolipoprotein A-I binding protein (AIBP). AIBP binds to toll-like receptor 4 (TLR4), a protein that sits on the surface of cells like an antenna, searching for signs of infection or tissue damage.

29 May 2018

Study: Sex hormone levels associated with increased risk of cardiovascular disease in older women

In an analysis of data collected from more than 2,800 women after menopause, Johns Hopkins researchers report new evidence that a higher proportion of male to female sex hormones was associated with a significant increased relative cardiovascular disease risk.

29 May 2018

Olfactory receptor in human bladder might prove useful for bladder cancer therapy, diagnosis

Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis.

29 May 2018

New research could advance art therapy for treating neurological and psychiatric disorders

Studies conducted at the University of Vienna by Marie Curie fellow Matthew Pelowski have contributed to the formation of the Vienna Integrated Model of Art Perception, a holistic framework within which the multiple cognitive processes underlying art viewing can be systematically organised.

29 May 2018

Therapy News and Research

Salk researchers discover molecule that destroys key HIV protein

Cancer cells can use lipid molecules as fuel for growth, shows study

Study finds reciprocal link between emotional distress and treatment side effects of prostate cancer

RaySearch signs research collaboration agreement with NIRS/QST for advancement of ion beam therapy

Prostate cancer survivors at higher risk of developing chronic diseases, study shows

Mesoblast and Cartherics form partnership to develop 'off-the-shelf' CAR-T therapies for solid cancers

Scientists introduce combination approach to fight cancer

UTSA scientists explore stuttering and develop new technology to optimize brain function

New guideline for HER2 testing in breast cancer benefits patients and clinicians

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Impaired maternal-fetal environment associated with lower survival after surgery in newborns with CHD

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

Male thyroid cancer survivors face nearly 50% higher CVD risk than women, study suggests

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

Scientists develop a new approach for efficient cancer therapy

Early-life seizures prematurely switch on key brain synapses related to autism

Single spinal injection reverses chemotherapy-induced pain for months in mice

Study: Sex hormone levels associated with increased risk of cardiovascular disease in older women

Olfactory receptor in human bladder might prove useful for bladder cancer therapy, diagnosis

New research could advance art therapy for treating neurological and psychiatric disorders

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News